| Emerging roles of lncRNA in cancer and therapeutic opportunities |
63 |
| Transferrin receptor 1 in cancer: a new sight for cancer therapy |
47 |
| Lipid metabolism and carcinogenesis, cancer development |
46 |
| First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia |
44 |
| Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche |
41 |
| The role of cholesterol metabolism in cancer |
31 |
| The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug |
30 |
| Fluid shear stress and tumor metastasis |
27 |
| Development and validation of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma |
26 |
| A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer |
25 |
| The metabolic modulator PGC-1 alpha in cancer |
24 |
| Exosome-mediated cell-cell communication in tumor progression |
24 |
| Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma |
23 |
| Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis |
23 |
| Energy stress-induced lncRNA HAND2-AS1 represses HIF1 alpha-mediated energy metabolism and inhibits osteosarcoma progression |
22 |
| The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research |
22 |
| An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications |
18 |
| Iron and magnetic: new research direction of the ferroptosis-based cancer therapy |
18 |
| EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway |
17 |
| A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia |
17 |
| Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing |
17 |
| miR-203a-3p promotes colorectal cancer proliferation and migration by targeting PDE4D |
17 |
| MicroRNA regulation of liver cancer stem cells |
17 |
| Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas |
16 |
| Target selection of CAR T cell therapy in accordance with the TME for solid tumors |
16 |
| HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRAS(Q)(61L) cells |
16 |
| Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents |
16 |
| Trends in the treatment of advanced hepatocelluar carcinoma: immune checkpoint blockade immunotherapy and related combination therapies |
16 |
| Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer |
15 |
| How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy |
15 |
| Circular RNA circ-ADD3 inhibits hepatocellular carcinoma metastasis through facilitating EZH2 degradation via CDK1-mediated ubiquitination |
15 |
| MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2 |
14 |
| Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling |
14 |
| The killing effect of novel bi-specific Trop2/PD-L1 CAR-T cell targeted gastric cancer |
14 |
| Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5 |
14 |
| Long non-coding RNA ANRIL promotes tumorgenesis through regulation of FGFR1 expression by sponging miR-125a-3p in head and neck squamous cell carcinoma |
14 |
| MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19 |
14 |
| A feedback loop consisting of RUNX2/LncRNA-PVT1/miR-455 is involved in the progression of colorectal cancer |
14 |
| Urine protein biomarkers for the detection, surveillance, and treatment response prediction of bladder cancer |
14 |
| Targeting PDK4 inhibits breast cancer metabolism |
14 |
| The positive feedback loop of lncRNA DANCR/miR-138/Sox4 facilitates malignancy in non-small cell lung cancer |
13 |
| LncRNA LINC00163 upregulation suppresses lung cancer development though transcriptionally increasing TCF21 expression |
13 |
| miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells |
13 |
| Respiratory hyperoxia reverses immunosuppression by regulating myeloid-derived suppressor cells and PD-L1 expression in a triple-negative breast cancer mouse model |
12 |
| New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies |
12 |
| The contrasting roles of inflammasomes in cancer |
12 |
| Exosomes in cancer therapy: a novel experimental strategy |
12 |
| The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs |
12 |
| MicroRNA-485-5p attenuates cell proliferation in glioma by directly targeting paired box 3 |
12 |
| Circular RNAs: an emerging landscape in tumor metastasis |
12 |
